In a filing, Stoke Therapeutics Inc revealed its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $52379.0 on Jul 01 ’25. In the deal valued at $11.63 per share,4,503 shares were sold. As a result of this transaction, Ticho Barry now holds 21,279 shares worth roughly $0.25 million.
Then, BARUCH TICHO bought 9,007 shares, generating $102,229 in total proceeds.
Before that, Skorpios Trust sold 3,000,000 shares. Stoke Therapeutics Inc shares valued at $30,600,000 were divested by the 10% Owner at a price of $10.20 per share. As a result of the transaction, Skorpios Trust now holds 3,906,181 shares, worth roughly $45.66 million.
Chardan Capital Markets initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on December 20, 2024; the price target was $24. TD Cowen also remained covering STOK and has increased its forecast on March 26, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of STOK
On Monday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 1.83% to $11.69. Over the last five days, the stock has gained 0.52%. Stoke Therapeutics Inc shares have fallen nearly -8.89% since the year began. Nevertheless, the stocks have risen 5.98% over the past one year. While a 52-week high of $16.15 was reached on 02/05/25, a 52-week low of $5.35 was recorded on 04/09/25.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 11.48, which if violated will result in even more drops to 11.26. On the upside, there is a resistance level at 11.85. A further resistance level may holdings at 12.01.
